首页> 外国专利> method for isolating a central sedative effects isovaleriansaeureesters from waessrigen valerian extracts

method for isolating a central sedative effects isovaleriansaeureesters from waessrigen valerian extracts

机译:法从瓦斯瑞根缬草提取物中分离出具有镇静作用的异戊酸脲酸酯

摘要

The invention comprises an Isovaleric acid ester of the molecular formula C22H30O8 molecular weight 422.46 having a U.V. spectrum with max1 = 256 mm (e = 15010) and max2 = 204 mm (e = 3800) in methanol and IR- and NMR-spectra according to Figs. 1 and 2 (not shown) and the process for the isolation of the above Isovaleric acid ester sedative comprising the chromographic separation from a non-aqueous valerian extract, of the isovaleric acid ester sedative on aluminium oxide which has been partially inactivated by treatment in a non-aqueous medium with a carboxylic acid having from 2-7 carbon atoms in the molecule, and elution therefrom with a non-aqueous solvent preferably of the first range of the eluotropic series or a corresponding isoeluotropic mixture.ALSO:Aluminium oxide which has been partially inactivated by treatment of a commercial aluminium oxide, preferably a neutral or basic aluminium oxide standardized according to Brockman, in a non-aqueous medium, preferably in a lipophilic solvent. Dioxane, acetone or an ester such as amylacetate or glycerine monoacetate or mixtures thereof may be added during the treatment of the aluminium oxide. The inactivated aluminium oxide is used in the isolation of an isovaleric acid ester (see Division C2).ALSO:The invention comprises an Isovaleric acid ester of the molecular formula C22H30O8 molecular weight 422.46 having a UV-spectrum with max1 = 256 mm (e = 15010) and max2 = 204 mm (e = 3800) in methanol and IR-and NMR-spectra according to Figs. 1 and 2 respectively of the accompanying drawings and the process for the isolation of the above Isovaleric acid ester sedative comprising the chromographic separation from a non aqueous valerian extract, of the isovaleric acid ester sedative on aluminium oxide which has been partially inactivated by treatment in a non aqueous medium with a carboxylic acid having from 2-7 carbon atoms in the molecule, and elurion therefrom with a non aqueous solvent preferably of the first range of the eluotropic series or a corresponding isoeluotropic mixture.
机译:本发明包括具有U.V的分子式为C22H30O8的分子量为422.46的异戊酸酯。在甲醇和IR和NMR光谱中,max1 = 256 mm(e = 15010)和max2 = 204 mm(e = 3800)的质谱图。图1和图2(未示出)以及上述异戊酸酯镇静剂的分离方法,包括从非水缬草提取物中色谱分离的异戊酸酯镇静剂在氧化铝上的作用,该镇静剂已通过在二氯甲烷中的处理而部分失活。分子中具有2-7个碳原子的羧酸的非水介质,并用非水溶剂进行洗脱,该溶剂最好是亲电系列的第一个范围或相应的等电混合物.ALSO:氧化铝通过在非水介质中,优选在亲脂性溶剂中处理市售氧化铝,优选根据布罗克曼标准的中性或碱性氧化铝来部分灭活。可以在氧化铝的处理过程中加入二恶烷,丙酮或酯,例如乙酸戊酯或甘油单乙酸酯或它们的混合物。灭活的氧化铝用于分离异戊酸酯(参见C2部分)。ALSO:本发明包括分子式为C22H30O8的分子量为422.46的异戊酸酯,其UV光谱为max1 = 256 mm(e =甲醇和IR和NMR光谱中的max2 = 204 mm(e = 3800)= 15010)。分别参见附图的图1和图2以及上述的异戊酸酯类镇静剂的分离方法,其包括从非水缬草提取物中进行色谱分离的氧化铝上的异戊酸酯类镇静剂,该异戊酸酯类镇静剂通过在二氯甲烷中的处理而被部分灭活。非水介质,其分子中具有2-7个碳原子的羧酸,并用非水溶剂从Elurion中洗脱,该非水溶剂优选为Eleotropic系列的第一个范围或相应的Eleoeltropic混合物。

著录项

  • 公开/公告号SE323472B

    专利类型

  • 公开/公告日1970-05-04

    原文格式PDF

  • 申请/专利权人 KALI CHEMIE AG;

    申请/专利号SE19640009126

  • 发明设计人 THIES P;KUCABA W;FUNKE S;

    申请日1964-07-27

  • 分类号A61K27/14;

  • 国家 SE

  • 入库时间 2022-08-23 11:32:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号